Downstream Use of SPL:

---

Please join wikispaces (it's free!) so that you can participate in discussions.

Objective:

---

What is Downstream Use of SPL? We all know how SPL is utilized daily for labeling and drug listing purposes. Downstream use of SPL is about recognizing and exploring potential uses of SPL. This group will work to identify factors on how we can maximize the use of SPL within our industry as well as outside of the pharmaceutical industry.

On this page, you will find information of coming conferences, presentations, newsletters and e-books specific to Downstream use of SPL, meeting minutes and up-to-date developments in the world of downstream uses.

DUSPLS Groups: Co Chairs: Virginia Hogan, Jacqueline Mohns, John Lorenc and Lonnie Smith.

Communication: Chair: Craig Trautman

Outreach: Chair: Virginia Hogan; Members: Mona Desai and Howard Shatz

Data Research: Chair: Jackie Mohns

Wiki Page: Chair: Mona Desai

Upcoming Meetings:

---

Downstream Use of SPL Sub-Group Meeting:

Agenda: Using SPL Data in Drug Products' Promotional/Commercial Materials
Date & Time: Thursday, September 26th, 2013 at 3:00 pm - 4:00 pm EST
Teleconference: 1-866-775-9435
Pin: 5753366

Agenda: Discussion of new developments regarding indexing
Date & Time: Thursday,October 24th, 2013 at 1:00 pm - 2:00 pm EST
Teleconference: TBD
Pin: TBD

Agenda: SPL's "Freeness" Data Element
Date & Time: Thursday, October 24th, 2013 at 3:00 pm - 4:00 pm EST
Teleconference: 1-866-775-9435
Pin: 5753366

Agenda: Indexing SPL Data (Pharmacologic Class, Billing Unit, Etc.)
Date & Time: Thursday, November 21st, 2013 at 3:00 pm - 4:00 pm EST
Teleconference: 1-866-775-9435
Pin: 5753366

e-Books:

---

Use of SPL Data in Healthcare Information Systems - Part Two



Use of SPL Data in Healthcare Information Systems - Part One

SPL-Infographics:

---

The SPL Index Connection

Empowering the Patient/Consumer Using SPL

Use of SPL by Federal Government Agencies

Newsletters:

---

June 2013:

Excel Files:

---

Medication Guide Project



Tips and Tricks:

---

• Medication Guide (MG) should be authored as a major section utilizing the Medication Guide Section LOINC
• MG should appear before the Principal Display Panel Section
• The Company Signature and Revision Date should be included in the MG Section
• Draft Labeling should not be posted to DailyMed. If final labeling with approved Recent Major Changes is listed, ensure the revision dates are populated.

Presentations:

---

4th Annual Pharma Packaging and Labeling Conference
February 28th - February 29th, 2012
Topic: SPL Update and Downstream Use
Speaker: Virginia Hogan, Teva Pharmaceuticals



HL7 Plenary Meeting
September 10, 2012
Topic: Accessing Structured Product Labeling Data Via Mobile Devices
Speaker: Lonnie Smith, Food and Drug Administration



HL7 SPL- Downstream SPL Use Committee Meeting
September 27, 2012
Topic: The Role of Drug Compendia
Speaker: Kay Morgan, Gold Standard



Third Annual Pharmaceutical Labeling Summit
October 15-16, 2012
Topic: Downstream Use of SPL
Speaker: Mona Desai, Interchem Corporation

Third Annual Pharmaceutical Labeling Summit
October 15-16, 2012
Topic: Accessing Package Insert (CoL) Information via Mobile Devices
Speaker: Lonnie Smith, Food and Drug Administration

pharma_labeling_summit_spl_pres_oct_2012.pdf

• Details
• Download
• 2 MB

Discussions:

---

Let us start off the discussion with a very general question.

• What does Downstream Use of SPL mean to you?

Please visit the discussion page to share your thoughts and ideas on this topic. We look forward to discussing downstream use of SPL and its potential use in the future.




You can suggest topics by adding them to the Discussion tab on this page, or by sending an e-mail to Terry Brunone or Mona Desai.